Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and feasibility of carboplatin plus oral Navelbine in advanced NSCLC
2017-000659-23Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Aarhus University Hospital. Primary endpoint: Safety and feasibility of metronomic carboplatin plus Navelbine regimen. Started Aug 2017; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2017-000659-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000659-23.